Long-term survivors and gilteritinib safety beyond one year in FLT3-mutated R/R AML: ADMIRAL trial follow-up Meeting Abstract


Authors: Perl, A. E.; Martinelli, G.; Neubauer, A.; Berman, E.; Baer, M. R.; Larson, R. A.; Fathi, A. T.; Yokoyama, H.; Hosono, N.; Hasabou, N.; Lu, Q.; Bahceci, E.
Abstract Title: Long-term survivors and gilteritinib safety beyond one year in FLT3-mutated R/R AML: ADMIRAL trial follow-up
Meeting Title: 56th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 38
Issue: 15 Suppl.
Meeting Dates: 2020 May 29-31
Meeting Location: Virtual Conference
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2020-05-20
Language: English
ACCESSION: WOS:000560368303176
PROVIDER: wos
DOI: 10.1200/JCO.2020.38.15_suppl.7514
Notes: Meeting Abstract: 7514 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ellin Berman
    173 Berman